Stocks and Investing
Stocks and Investing
Tue, November 26, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, November 25, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Do Kim Maintained (ALNY) at Buy with Increased Target to $143 on, Nov 25th, 2019
Do Kim of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $138 to $143 on, Nov 25th, 2019.
Do has made no other calls on ALNY in the last 4 months.
There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 1 agrees with Do's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Esther Rajavelu of "UBS" Maintained at Hold with Increased Target to $96 on, Wednesday, September 4th, 2019
These are the ratings of the 4 analyists that currently disagree with Do
- David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $141 on, Thursday, November 21st, 2019
- Olivia Brayer of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $159 on, Thursday, November 21st, 2019
- Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $128 on, Wednesday, November 20th, 2019
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $145 on, Tuesday, September 3rd, 2019